Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)
Clinical trial NCT01862315 · COMPLETED
Trial details
- NCT number
- NCT01862315
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2025-03-18
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.